Press Releases
July 30, 2026
McGinnis studies cancer microenvironment complexity to create metastasis-targeted cancer therapeutics
July 30, 2026
Researchers from Dr. Katherine Aird’s lab found that ovarian cancer cells that survive chemotherapy release fructose as a cellular signaling molecule.
July 29, 2026
Dr. Jessive Villanueva’s lab has received a Breaking Barriers in Cancer Research Award from the V Foundation for Cancer Research. The $800,000 grant, enables her lab to pursue research into new poten…
July 23, 2026
Researchers showed that chemotherapy triggers an inflammatory cascade that recruits immune cells into the tumor microenvironment, which ultimately function to protect the cancer from subsequent chemo…
July 20, 2026
Novel DNA Delivery approach of Bispecific T Cell Engagers brings T cells to tumors, improving how they recognize and attack cancer
July 7, 2026
Joint Program between The Wistar Institute and Apprenti expands access to workforce development opportunities in Central New Jersey
June 26, 2026
While still preclinical, the study supports DNA delivery as a promising strategy for long-acting biologic therapies.
June 10, 2026
Schiffner merges biology, AI and reverse vaccinology to target HIV & emerging pandemic threats
May 27, 2026
For the first time, researchers have shown that a new metabolic process is altered in cancer cells that makes them resistant to DNA-damaging agents.
May 19, 2026
After more than a decade of transformational leadership at Wistar, Dr. Altieri returns to his lifelong passion of laboratory research and mentorship at Sidney Kimmel Medical College









